Zofkova Ivana, Hill Martin
Institute of Endocrinology, Prague, Czech Repulic.
Endocr Regul. 2008 Sep;42(4):121-7.
To evaluate the interrelations between circulating TSH and bone metabolism in postmenopausal women.
In a total of 60 postmenopausal women serum level of several hormones (thyrotropin [TSH], free thyroxine [FT4], dehydroepiandrosterone sulfate [DHEAS], parathyroid hormone [PTH]), bone turnover markers (carboxyterminal propeptide of type I procollagen [PICP] and cross-linked telopeptide of type I collagen [ICTP]) as well as of other compounds such as IGF-I, sex hormone binding globulin (SHBG), 25-OH vitamin D3 (25-OHD3) and urinary free deoxypyridinoline (Dpd (2h)) concentrations were estimated. Bone mineral density (BMD) at the spine and BMD at the hip were measured by DXA method.
Sperman's correlation showed negative association between serum TSH and urinary Dpd (p<0.021) and borderline, but not significant negative correlation between TSH and ICTP (p<0.064). However, no correlation was found between TSH and serum PICP. In addition, no correlation was found between FT4 and such parameters of bone remodeling. Expected positive association between serum IGF-I and DHEAS (p<0.000), between body mass index (BMI) and serum DHEAS (p<0.015) and negative correlation between BMI and SHGB (p<0.002) were confirmed. Moreover, negative correlation was found between bone mineral density at the hip and serum SHBG levels (p<0.000) and positive correlation between BMD at the hip and DHEAS level (p<0.003). Additionally, 36.5 % variability in TSH levels and 30.5% variability in FT4 in our cohort shared with the factor TSH and bone remodeling (factor analysis).
This cross-sectional study suggested negative association between serum TSH and markers of bone resorption in postmenopausal women. It also confirmed the well known mutual interrelations between BMD at the hip and a number of hormonal indices. Although our results did not provide any evidence on the effect of serum TSH and/or SHBG and DHEAS on bone metabolism, they showed some predictive value of these parameters to bone health.
评估绝经后女性循环促甲状腺激素(TSH)与骨代谢之间的相互关系。
共纳入60例绝经后女性,检测其多种激素(促甲状腺激素[TSH]、游离甲状腺素[FT4]、硫酸脱氢表雄酮[DHEAS]、甲状旁腺激素[PTH])、骨转换标志物(I型前胶原羧基端前肽[PICP]和I型胶原交联端肽[ICTP])以及其他化合物如胰岛素样生长因子-I(IGF-I)、性激素结合球蛋白(SHBG)、25-羟基维生素D3(25-OHD3)的血清水平,同时测定尿游离脱氧吡啶啉(Dpd(2h))浓度。采用双能X线吸收法(DXA)测量腰椎和髋部的骨密度(BMD)。
斯皮尔曼相关性分析显示,血清TSH与尿Dpd呈负相关(p<0.021),TSH与ICTP呈临界但不显著的负相关(p<0.064)。然而,TSH与血清PICP之间未发现相关性。此外,FT4与骨重塑的这些参数之间也未发现相关性。血清IGF-I与DHEAS之间预期的正相关(p<0.000)、体重指数(BMI)与血清DHEAS之间的正相关(p<0.015)以及BMI与SHGB之间的负相关(p<0.002)均得到证实。此外,髋部骨密度与血清SHBG水平呈负相关(p<0.000),髋部骨密度与DHEAS水平呈正相关(p<0.003)。另外,在我们的队列中,TSH水平36.5%的变异性和FT4水平30.5% 的变异性与TSH和骨重塑因子相关(因子分析)。
这项横断面研究提示绝经后女性血清TSH与骨吸收标志物之间存在负相关。同时也证实了髋部骨密度与一些激素指标之间众所周知的相互关系。尽管我们的结果没有提供血清TSH和/或SHBG及DHEAS对骨代谢影响的任何证据,但它们显示了这些参数对骨骼健康的一些预测价值。